New AAV-driven gene therapy for spastic paraplegia 47
Oct. 21, 2024
Spastic paraplegia type 47 (SPG47) is a rare congenital and neurological disorder characterized by dysfunction of the long axons in the corticospinal tract neurons that lead to progressive limb weakness and spasticity.